**Core Concept:**
After administering the Hepatitis B vaccine, the immune response is assessed through serum markers. Hepatitis B vaccination is a crucial measure in preventing Hepatitis B infection, which is caused by the hepatitis B virus (HBV). The vaccine stimulates the immune system to recognize and mount an immune response against the viral antigens present in the vaccine. Monitoring the immune response can help determine the vaccine's efficacy and whether an individual has developed immunity against HBV.

**Why the Correct Answer is Right:**
The correct answer is **D**: Hepatitis B surface antigen (HBsAg).

Hepatitis B surface antigen is a viral protein produced by the hepatitis B virus during the acute phase of infection. After vaccination, a positive HBsAg test indicates an individual has mounted an immune response to the vaccine and is likely immune to Hepatitis B. This is because the vaccine contains inactivated hepatitis B surface antigen, which stimulates the production of antibodies against this antigen.

**Why Each Wrong Option is Incorrect:**

**A.** Hepatitis B core antigen (HBcAg): HBcAg is produced during acute hepatitis B infection and is not useful for assessing vaccine efficacy.

**B.** Hepatitis B e antigen (HBeAg): HBeAg is produced during acute hepatitis B infection and is not the appropriate marker for assessing vaccine response.

**C.** Hepatitis B virus DNA polymerase: This is a viral enzyme that is involved in the replication of hepatitis B virus. It is not a serum marker for assessing vaccine efficacy.

**Clinical Pearl:**
Monitoring serum markers like HBsAg is essential in assessing the immune response to Hepatitis B vaccination. A positive HBsAg response indicates an individual has mounted an immune response to the vaccine and is likely immune to Hepatitis B infection. Monitoring these markers aids in assessing the vaccine's effectiveness and helps determine whether an individual is protected against Hepatitis B.